Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain

Cardiovascular Diagnosis Section, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892.

Twenty-six patients with dilated cardiomyopathy and angiographically normal coronary arteries, 12 of whom gave a history of anginal chest pain, underwent noninvasive and invasive hemodynamic study. During treadmill exercise testing, patients with a history of angina demonstrated worse effort tolerance (7.4 +/- 4.9 versus 13.6 +/- 5.1 minutes, p less than 0.005) and a lower end-exercise systolic blood pressure-heart rate product (17.9 +/- 3.4 versus 23.6 +/- 4.9 mm Hg.beats/min x 10(3), p less than 0.005) compared with patients without a history of angina. During rapid atrial pacing after ergonovine, 0.15 mg intravenously, 11 of the 12 patients with a history of angina experienced their typical chest pain, in contrast to only 1 of 12 patients without a history of angina. The angina group, compared with the nonangina group, had significantly lower great cardiac vein flow (118 +/- 24 versus 160 +/- 43 ml/min, p less than 0.01), and higher coronary resistance (0.87 +/- 0.21 versus 0.66 +/- 0.25 mm Hg.min/ml, p less than 0.05), significant widening of the arterial--great cardiac vein oxygen difference and a significant fall in cardiac index during pacing. Further, ergonovine resulted in higher coronary resistance during pacing in the angina group compared with pacing alone (+0.16 +/- 0.16 mm Hg min/ml, p less than 0.01), in the absence of significant reduction in epicardial coronary artery luminal diameter. After dipyridamole, 0.5 to 0.75 mg/kg intravenously, to 21 patients, the 7 patients with a history of angina had significantly lower flow (149 +/- 37 versus 218 +/- 73 ml/min, p less than 0.05) and higher coronary resistance (0.59 +/- 0.09 versus 0.43 +/- 0.17 mm Hg.min/ml, p less than 0.05) than did the nonangina group. It is concluded that patients with dilated cardiomyopathy and chest pain unrelated to epicardial coronary artery disease exhibit impaired vasodilator responses to both metabolic and pharmacologic stimuli, and an increased sensitivity to the vasoconstrictor effects of ergonovine. Whether these findings are of etiologic or long-term prognostic significance is unknown.

This article has been cited by other articles:

				E. P. Tsagalou, M. Anastasiou-Nana, E. Agapitos, A. Gika, S. G. Drakos, J. V. Terrovitis, A. Ntalianis, and J. N. Nanas Depressed Coronary Flow Reserve Is Associated With Decreased Myocardial Capillary Density in Patients With Heart Failure Due to Idiopathic Dilated Cardiomyopathy J. Am. Coll. Cardiol., October 21, 2008; 52(17): 1391 - 1398. [Abstract] [Full Text] [PDF]

				D. Erdogan, H. Gullu, M. Caliskan, O. Ciftci, S. Baycan, A. Yildirir, and H. Muderrisoglu Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy Heart, March 1, 2007; 93(3): 319 - 324. [Abstract] [Full Text] [PDF]

				F. Rigo, S. Gherardi, M. Galderisi, L. Pratali, L. Cortigiani, R. Sicari, and E. Picano The prognostic impact of coronary flow-reserve assessed by Doppler echocardiography in non-ischaemic dilated cardiomyopathy Eur. Heart J., June 1, 2006; 27(11): 1319 - 1323. [Abstract] [Full Text] [PDF]

				K. Sugioka, T. Hozumi, Y. Takemoto, K. Ujino, Y. Matsumura, H. Watanabe, K. Fujimoto, M. Yoshiyama, and J. Yoshikawa Early recovery of impaired coronary flow reserve by carvedilol therapy in patients with idiopathic dilated cardiomyopathy: A serial transthoracic Doppler echocardiographic study J. Am. Coll. Cardiol., January 18, 2005; 45(2): 318 - 319. [Full Text] [PDF]

				L. A. Nikolaidis, D. Trumble, T. Hentosz, A. Doverspike, R. Huerbin, M. A. Mathier, Y.-T. Shen, and R. P. Shannon Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure) Eur J Heart Fail, June 1, 2004; 6(4): 409 - 419. [Abstract] [Full Text] [PDF]

				M. Mohri, H. Shimokawa, Y. Hirakawa, A. Masumoto, and A. Takeshita Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm J. Am. Coll. Cardiol., January 1, 2003; 41(1): 15 - 19. [Abstract] [Full Text] [PDF]

				L. A. Nikolaidis, A. Doverspike, R. Huerbin, T. Hentosz, and R. P. Shannon Angiotensin-Converting Enzyme Inhibitors Improve Coronary Flow Reserve in Dilated Cardiomyopathy by a Bradykinin-Mediated, Nitric Oxide-Dependent Mechanism Circulation, June 11, 2002; 105(23): 2785 - 2790. [Abstract] [Full Text] [PDF]

				D. Neglia, C. Michelassi, M. G. Trivieri, G. Sambuceti, A. Giorgetti, L. Pratali, M. Gallopin, P. Salvadori, O. Sorace, C. Carpeggiani, et al. Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction Circulation, January 15, 2002; 105(2): 186 - 193. [Abstract] [Full Text] [PDF]

				T. Saito, K. Maehara, K. Tamagawa, Y. Oikawa, T. Niitsuma, S.-I. Saitoh, and Y. Maruyama Alterations of endothelium-dependent and -independent regulation of coronary blood flow during heart failure Am J Physiol Heart Circ Physiol, January 1, 2002; 282(1): H80 - H86. [Abstract] [Full Text] [PDF]

				R. Nakamura, K. Egashira, K. Arimura, Y. Machida, T. Ide, H. Tsutsui, H. Shimokawa, and A. Takeshita Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2619 - H2625. [Abstract] [Full Text] [PDF]

				Y. Oikawa, K. Maehara, T. Saito, K. Tamagawa, and Y. Maruyama Attenuation of angiotensin II-mediated coronary vasoconstriction and vasodilatory action of angiotensin-converting enzyme inhibitor in pacing-induced heart failure in dogs J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1188 - 1194. [Abstract] [Full Text] [PDF]

				M.L Geleijnse, C Vigna, J.D Kasprzak, R Rambaldi, M.P Salvatori, A Elhendy, J.H Cornel, P.M Fioretti, and J.R.T.C Roelandt Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study Eur. Heart J., October 2, 2000; 21(20): 1666 - 1673. [Abstract] [PDF]

				W. M. Chilian Coronary Microcirculation in Health and Disease: Summary of an NHLBI Workshop Circulation, January 21, 1997; 95(2): 522 - 528. [Abstract] [Full Text]

				D. Neglia, O. Parodi, M. Gallopin, G. Sambuceti, A. Giorgetti, L. Pratali, P. Salvadori, C. Michelassi, M. Lunardi, G. Pelosi, et al. Myocardial Blood Flow Response to Pacing Tachycardia and to Dipyridamole Infusion in Patients With Dilated Cardiomyopathy Without Overt Heart Failure : A Quantitative Assessment by Positron Emission Tomography Circulation, August 15, 1995; 92(4): 796 - 804. [Abstract] [Full Text]

				C. G. Gustavsson, S. U. Persson, H. Larsson, and S. Persson Changed Blood Rheology in Patients With Idiopathic Dilated Cardiomyopathy Angiology, February 1, 1994; 45(2): 107 - 111. [Abstract] [PDF]

				G. J. Magarian, R. Palac, and S. Reinhart Syndrome of Diminished Vasodilator Reserve of the Coronary Microcirculation (Microvascular Angina or Syndrome X): Diagnosis by Combined Atrial Pacing and Thallium 201 Imaging A Case Report Angiology, August 1, 1990; 41(8): 667 - 672. [Abstract] [PDF]